Dr. Stasi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
51 N 39th St
Scheie Eye Institute
Philadelphia, PA 19104Phone+1 215-662-8100Fax+1 215-662-1721
Education & Training
- University of RochesterResidency, Ophthalmology, 2005 - 2008
- Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Internship, Internal Medicine, 2004 - 2005
- University of Patras School of MedicineClass of 1991
Certifications & Licensure
- PA State Medical License 2009 - 2024
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Publications & Presentations
PubMed
- 9 citationsTopical Ocular TRPV1 Antagonist SAF312 (Libvatrep) for Postoperative Pain After Photorefractive Keratectomy.Vance Thompson, Majid Moshirfar, Thomas Clinch, Stephen Scoper, Steven H Linn
Translational Vision Science & Technology. 2023-03-01 - 43 citationsTear osmolarity and dry eye symptoms in diabetics.Nicole M. Fuerst, Nicole Langelier, Mina Massaro-Giordano, Maxwell Pistilli, Kalliopi Stasi
Clinical Ophthalmology. 2014-03-10 - 7 citationsTopical Ocular TRPV1 Antagonist SAF312 (Libvatrep) Demonstrates Safety, Low Systemic Exposure, and No Anesthetic Effect in Healthy Participants.Kalliopi Stasi, Qusai Alshare, Monish Jain, Michael Wald, Yifang Li
Translational Vision Science & Technology. 2022-11-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: